Oxford Covid-19 vaccine trials produce robust immune response in elderly - FT
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
MONDAY, MAY 16, 2022
MONDAY, MAY 16, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Oxford Covid-19 vaccine trials produce robust immune response in elderly - FT

Coronavirus chronicle

Reuters
26 October, 2020, 01:05 pm
Last modified: 26 October, 2020, 02:52 pm

Related News

  • North Korea reports 15 more suspected Covid-19 deaths
  • New Zealand Prime Minister Jacinda Ardern tests positive for Covid
  • North Korea's Kim says Covid 'great turmoil' as 21 new deaths reported
  • How N Korea's Covid-19 outbreak could ignite a major health crisis
  • China denies suspending passports, invalidating foreign residency cards

Oxford Covid-19 vaccine trials produce robust immune response in elderly - FT

But the FT cautioned that positive immunogenicity tests do not guarantee that the vaccine will ultimately prove safe and effective in older people

Reuters
26 October, 2020, 01:05 pm
Last modified: 26 October, 2020, 02:52 pm
Britain's Medicines and Healthcare products Regulatory Agency (MHRA) started an accelerated "rolling review" of the vaccine at the start of this month as data comes in on safety and efficacy. Photo: Reuters
Britain's Medicines and Healthcare products Regulatory Agency (MHRA) started an accelerated "rolling review" of the vaccine at the start of this month as data comes in on safety and efficacy. Photo: Reuters

Early results from tests for a coronavirus vaccine being developed by the University of Oxford, in collaboration with AstraZeneca Plc AZN.L, show it produces a robust immune response in elderly people, the group at highest risk, the Financial Times reported on Monday.

It has been discovered that the vaccine triggers protective antibodies and T-cells in older age groups, the newspaper said on.ft.com/3kxKyJI, citing two people familiar with the finding, encouraging researchers as they seek evidence that it will spare those in later life from serious illness or death from the virus.

The findings echo data released in July which showed the vaccine generated "robust immune responses" in a group of healthy adults aged between 18 and 55, the newspaper reported, citing people aware of the results from so-called immunogenicity blood tests.

But the FT cautioned that positive immunogenicity tests do not guarantee that the vaccine will ultimately prove safe and effective in older people.

AstraZeneca, which is developing the vaccine with Oxford University researchers, is seen as a frontrunner in the race to produce a vaccine to protect against Covid-19.

Details of the finding are expected to be published shortly in a clinical journal, the FT said, without naming a journal.

Oxford and AstraZeneca did not immediately respond to Reuters' request for comments.

Top News / World+Biz

Oxford / Covid -19

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Citizen's platform for monthly Tk1,000 allowance for unemployed youths 
    Citizen's platform for monthly Tk1,000 allowance for unemployed youths 
  • Photo: PID
    Make best use of funds in effective implementation of SDGs: PM Hasina
  • BPC will sell cheap bulk LPG to private companies due to low bottling capacity
    BPC will sell cheap bulk LPG to private companies due to low bottling capacity

MOST VIEWED

  • A medical worker in a protective suit collects a swab from a resident at a makeshift nucleic acid testing site inside a residential compound under lockdown, amid the coronavirus disease (COVID-19) outbreak in Shanghai, China April 14, 2022. REUTERS/Xihao Jiang
    Shanghai aims for return to normal life from 1 June
  • South Korea's new President Yoon Suk-yeol signs a document as he works at the new Presidential office in Seoul, South Korea, May 10, 2022. Yonhap via REUTERS/File Photo
    S Korea says it will spare no effort to help North Korea amid Covid outbreak
  • North Korean leader Kim Jong Un wears a face mask amid the coronavirus disease (Covid-19) outbreak, while inspecting a pharmacy in Pyongyang, in this undated photo released by North Korea's Korean Central News Agency (KCNA) on May 15, 2022. KCNA via REUTERS
    Kim Jong Un orders North Korea military to 'stabilise' drug supply amid Covid outbreak
  • North Korea reports 15 more suspected Covid-19 deaths
    North Korea reports 15 more suspected Covid-19 deaths
  • Residents line up for nucleic acid tests during lockdown, amid the coronavirus disease (Covid-19) pandemic, in Shanghai, China, May 9, 2022. REUTERS/Aly Song
    Locked-down Shanghai to start gradually reopening malls, other businesses
  • North Korean leader Kim Jong Un visits the State Emergency Epidemic Prevention Headquarters, as North Korea reports its first outbreak of the coronavirus disease (COVID-19), in Pyongyang, North Korea, May 12, 2022, in this photo released by North Korea's Korean Central News Agency (KCNA). Picture taken May 12, 2022. KCNA via REUTERS
    North Korea's Kim says Covid 'great turmoil' as 21 new deaths reported

Related News

  • North Korea reports 15 more suspected Covid-19 deaths
  • New Zealand Prime Minister Jacinda Ardern tests positive for Covid
  • North Korea's Kim says Covid 'great turmoil' as 21 new deaths reported
  • How N Korea's Covid-19 outbreak could ignite a major health crisis
  • China denies suspending passports, invalidating foreign residency cards

Features

Bitcoin, by far the largest cryptocurrency, is a terrible substitute for government-issued money. Photo: Reuters

Crypto’s wild week offers a much-needed warning

1h | Panorama
Karst Stone Paper Journal: Write on indestructible stone paper

Karst Stone Paper Journal: Write on indestructible stone paper

2h | Brands
Pesky bugs do not stand a chance against this automatic indoor insect trap

Pesky bugs do not stand a chance against this automatic indoor insect trap

2h | Brands
Wazeenah: Turning furniture into a canvas

Wazeenah: Turning furniture into a canvas

3h | Brands

More Videos from TBS

How can you become proficient as a new team leader?

5h | Videos
Future of newborn baby genome sequencing: Good or Bad?

Future of newborn baby genome sequencing: Good or Bad?

5h | Videos
What Europe-based Fair Wear says about fair price of Bangladeshi cloth

What Europe-based Fair Wear says about fair price of Bangladeshi cloth

18h | Videos
Microplastics found in 5 local sugar brands

Microplastics found in 5 local sugar brands

19h | Videos

Most Read

1
The hostile welcome to Bangladesh
Bangladesh

The hostile welcome to Bangladesh

2
Representative Photo: Pixabay.
Bangladesh

Microplastics found in 5 local sugar brands

3
Mushfiq Mobarak. Photo: Noor-A-Alam
Panorama

Meet the Yale professor who anchors his research in Bangladesh and scales up interventions globally

4
Union Capital asked to return Tk100cr FDR to BATBC 
Banking

Union Capital asked to return Tk100cr FDR to BATBC 

5
Bangladesh gas fields burnt $3m worth of gas in the air in 2021
Energy

Bangladesh gas fields burnt $3m worth of gas in the air in 2021

6
Impact of falling taka against US dollar
Banking

Taka losing more value as global currency market volatility persists

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab